These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2505028

  • 1. Pergolide and selegiline for Parkinson's disease.
    Med Lett Drugs Ther; 1989 Sep 08; 31(800):81-3. PubMed ID: 2505028
    [No Abstract] [Full Text] [Related]

  • 2. Selegiline for Parkinson's disease.
    Calesnick B.
    Am Fam Physician; 1990 Feb 08; 41(2):589-91. PubMed ID: 2105624
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deprenyl in Parkinson's disease.
    Lancet; 1982 Sep 25; 2(8300):695-6. PubMed ID: 6126632
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
    Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Bihari K.
    Adv Neurol; 1984 Sep 25; 40():549-56. PubMed ID: 6421113
    [No Abstract] [Full Text] [Related]

  • 7. Deprenyl in the treatment of Parkinson's disease. A specific type B monoamine oxidase inhibitor.
    Lieberman AN, Gopinathan G, Neophytides A, Hiesiger E, Nelson J, Walker R, Goodgold A.
    N Y State J Med; 1984 Jan 25; 84(1):13-6. PubMed ID: 6422358
    [No Abstract] [Full Text] [Related]

  • 8. Pergolide and Parkinson's disease: new preparation. No clear benefit.
    Prescrire Int; 2000 Dec 25; 9(50):177-9. PubMed ID: 11475497
    [Abstract] [Full Text] [Related]

  • 9. Deprenyl and the progression of Parkinson's disease.
    Science; 1990 Jul 20; 249(4966):303-4. PubMed ID: 2115691
    [No Abstract] [Full Text] [Related]

  • 10. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug 20; 11(60):108-11. PubMed ID: 12199263
    [Abstract] [Full Text] [Related]

  • 11. R-(-)-deprenyl as an adjuvant to levodopa in the treatment of Parkinson's disease.
    Rinne UK.
    J Neural Transm Suppl; 1987 Aug 20; 25():149-55. PubMed ID: 3123601
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Parkinson's disease.
    Eadie MJ.
    Aust Fam Physician; 1995 Sep 20; 24(9):1685-7, 1690-2. PubMed ID: 7487655
    [Abstract] [Full Text] [Related]

  • 13. R-(-)-deprenyl as a possible protective agent in Parkinson's disease.
    Tetrud JW, Langston JW.
    J Neural Transm Suppl; 1987 Sep 20; 25():69-79. PubMed ID: 3123606
    [Abstract] [Full Text] [Related]

  • 14. L-deprenyl in the treatment of Parkinson's disease.
    Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Katona G.
    J Neural Transm Suppl; 1983 Sep 20; 19():283-90. PubMed ID: 6421993
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of the effectiveness of combined (L-dopa + Jumex) therapy based on a multicentric double blind study].
    Tariska I, Gallai M.
    Orv Hetil; 1983 Sep 18; 124(38):2309-14. PubMed ID: 6415577
    [No Abstract] [Full Text] [Related]

  • 16. (-)Deprenyl in Parkinson's disease: a two-year study in the different evolutive stages.
    Giovannini P, Martignoni E, Piccolo I, Pacchetti C, Grassi MP, Nappi G, Caraceni T.
    J Neural Transm Suppl; 1986 Sep 18; 22():235-46. PubMed ID: 3097258
    [Abstract] [Full Text] [Related]

  • 17. Selegiline in the early and late phases of Parkinson's disease.
    Csanda E, Tárczy M.
    J Neural Transm Suppl; 1987 Sep 18; 25():105-13. PubMed ID: 3123597
    [Abstract] [Full Text] [Related]

  • 18. Effect of (-)deprenyl in long-term treatment of Parkinson's disease. A 10-years experience.
    Birkmayer W, Birkmayer GD.
    J Neural Transm Suppl; 1986 Sep 18; 22():219-25. PubMed ID: 3097256
    [Abstract] [Full Text] [Related]

  • 19. Pergolide mesylate: four years experience in Parkinson's disease.
    Tanner CM, Goetz CG, Glantz RH, Klawans HL.
    Adv Neurol; 1987 Sep 18; 45():547-9. PubMed ID: 3825732
    [No Abstract] [Full Text] [Related]

  • 20. Parallel double-blind study of pergolide in Parkinson's disease.
    Jankovic J, Orman J.
    Adv Neurol; 1987 Sep 18; 45():551-4. PubMed ID: 3548265
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.